Hypertrophic scarring is a skin disorder that occurs after wounding and the
rmal injury. There is accumulating evidence that immunologic processes such
as infiltration of activated T lymphocytes and altered cytokine production
may play a role in the formation of hypertrophic scars. Interleukin-15, a
cytokine identified as a T cell growth factor, also acts as a chemoattracta
nt for T cells and has pro-inflammatory properties. We investigated the exp
ression and the role of this cytokine in hypertrophic scarring. IL-15 expre
ssion was compared in skin biopsies of hypertrophic scars (HS) both in acti
ve (AHS) and in remission (RHS) phases, in normotrophic scars (NTS) and in
normal skin using reverse transcriptase-polymerase chain reaction and immun
ohistochemistry. IL-15 expression in HS was significantly higher than in NT
S or normal skin. Furthermore, AHS expressed higher levels of IL-15 than RH
S. Immunohistologic analysis ofAHS samples showed strong IL15 immunoreactiv
ity in keratinocytes and Langerhans cells in the epidermis and in macrophag
es, fibroblasts, and dermal dendritic cells in the dermis, High levels of I
L-15 expression in AHS correlated with abundant infiltration of activated C
D3(+) cells. Ex vivo experiments indicate that IL-15 can sustain the prolif
erative response of T cells derived from AHS but not from RHS and NTS. In a
ddition, IL-15 prevents both cytokine deprivation and activation-induced ap
optosis of T cells derived from AHS. Taken together, these results suggest
that IL-15 can be involved in the recruitment, proliferation, and apoptosis
inhibition of T cells in AHS, The findings that the evolution from an AHS
to a RHS is associated with a decrease in IL-15 expression, and with a loss
of IL-15 responsiveness in ex vivo-cultured T cells, indicate that this cy
tokine plays an important role in the biology of pathologic scar formation.